Genmab — Februar 2020
-
Der er udsigt til en indledende nervøs dansk aktiehandel med mindre fald. Der er dog ikke udsigt til nogen meget negativ start. Dels har aktierne allerede reageret lidt på Corona og dels er smitten trods alt koncentreret i Kina. https://blog.nordnet.dk/kinesisk-aktiepanik/?fbclid=IwAR2uFmmTg2dY_EngYOZADiYu-upTuHDoDQC5Bbv3G3IYJBJOxbcD8QdALHE
-
CNBC
·US futures point to higher open despite coronavirus fears. https://www.cnbc.com/2020/02/03/us-futures-point-to-higher-open-despite-coronavirus-fears.html?__source=twitter|main
-
Antibody-drug conjugates on the march
One of AstraZeneca’s most decisive moves last year came when it signed a multi-billion dollar deal with Daiichi Sankyo, focused on just one breast cancer drug. We spoke with Daiichi's Gilles Gallant about the future plans for the drug, and the antibody-drug conjugate technology behind it
pharmaphorum (pharmaphorum.com)
-
ofatumumab may represent an additional option to treat post-transplant FSGS relapse in patients who respond poorly to rituximab. Our experience suggests that its effectiveness could be related to prolonged depletion of potentially pathogenic switched memory B cells. Pediatric Nephrology volume 35, pages341–345(2020)
-
Er der et nyt marked for Ofa i CLL?
-
Jeg troede at Ofa var en død sild i cancer?
-
-
God morgen.

-
Abwehrkampf gegen Leukämie - https://www.welt.de/print/die_welt/article205575129/Abwehrkampf-gegen-Leukaemie.html
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind